Upregulation of programmed death ligand-1 in tumor-associated macrophages affects chemotherapeutic response in ovarian cancer cells

To better understand the mechanism of chemoresistance in ovarian cancer cells, we aimed to investigate the influence of macrophages on the tumor cell response to carboplatin and identify the genes associated with chemoresistance. We mimicked the tumor microenvironment (TME) using a co-culture techni...

Full description

Bibliographic Details
Main Authors: Yong Soo Jang, Tae Wan Kim, Jae Sung Ryu, Hye Jeong Kong, Si Hyeong Jang, Gye Hyun Nam, Jae Hoon Kim, Seob Jeon
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910707/?tool=EBI
_version_ 1811166140252028928
author Yong Soo Jang
Tae Wan Kim
Jae Sung Ryu
Hye Jeong Kong
Si Hyeong Jang
Gye Hyun Nam
Jae Hoon Kim
Seob Jeon
author_facet Yong Soo Jang
Tae Wan Kim
Jae Sung Ryu
Hye Jeong Kong
Si Hyeong Jang
Gye Hyun Nam
Jae Hoon Kim
Seob Jeon
author_sort Yong Soo Jang
collection DOAJ
description To better understand the mechanism of chemoresistance in ovarian cancer cells, we aimed to investigate the influence of macrophages on the tumor cell response to carboplatin and identify the genes associated with chemoresistance. We mimicked the tumor microenvironment (TME) using a co-culture technique and compared the proliferation of ovarian cells with and without macrophages. We also examined M1 and M2 marker expression and the expression of key TME genes. Post the co-culture, we treated ovarian cancer cells with carboplatin and elucidated the function of programmed death–ligand 1 (PD-L1) in carboplatin chemoresistance. We investigated CD68 and PD-L1 expression in normal and cancerous ovarian tissues using immunohistochemistry (IHC). Finally, we analyzed the association between CD68 or PD-L1 expression and survival outcomes. Inducible nitric oxide synthase (iNOS) was downregulated, while the gene expression of M2 macrophage markers was increased in ovarian cancer cells. PD-L1, vascular endothelial growth factor (VEGF), Interleukin (IL)-6, IL-10, IL-12, signal transducer and activator of transcription 3 (STAT3), B-cell lymphoma 2 (BCL2), multidrug resistance 1 (MDR1), and colony stimulating factor 1 (CSF-1) were upregulated. Notably, PD-L1 was upregulated in both the ovarian cancer cells and macrophages. Ovarian cancer cells co-cultured with macrophages exhibited statistically significant carboplatin resistance compared to single-cultured ovarian cancer cells. PD-L1 silencing induced chemosensitivity in both types of co-cultured ovarian cancer cells. However, IHC results revealed no correlation between PD-L1 expression and patient survival or cancer stage. CD68 expression was significantly increased in cancer cells compared to normal or benign ovarian tumor cells, but it was not associated with the survival outcomes of ovarian cancer patients. Our study demonstrated that ovarian cancer cells interact with macrophages to induce the M2 phenotype. We also established that PD-L1 upregulation in both ovarian cancer cells and macrophages is a key factor for carboplatin chemoresistance.
first_indexed 2024-04-10T15:47:43Z
format Article
id doaj.art-ae891557ffa04efca2b2e20e2b2fb05a
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-10T15:47:43Z
publishDate 2023-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-ae891557ffa04efca2b2e20e2b2fb05a2023-02-12T05:31:13ZengPublic Library of Science (PLoS)PLoS ONE1932-62032023-01-01182Upregulation of programmed death ligand-1 in tumor-associated macrophages affects chemotherapeutic response in ovarian cancer cellsYong Soo JangTae Wan KimJae Sung RyuHye Jeong KongSi Hyeong JangGye Hyun NamJae Hoon KimSeob JeonTo better understand the mechanism of chemoresistance in ovarian cancer cells, we aimed to investigate the influence of macrophages on the tumor cell response to carboplatin and identify the genes associated with chemoresistance. We mimicked the tumor microenvironment (TME) using a co-culture technique and compared the proliferation of ovarian cells with and without macrophages. We also examined M1 and M2 marker expression and the expression of key TME genes. Post the co-culture, we treated ovarian cancer cells with carboplatin and elucidated the function of programmed death–ligand 1 (PD-L1) in carboplatin chemoresistance. We investigated CD68 and PD-L1 expression in normal and cancerous ovarian tissues using immunohistochemistry (IHC). Finally, we analyzed the association between CD68 or PD-L1 expression and survival outcomes. Inducible nitric oxide synthase (iNOS) was downregulated, while the gene expression of M2 macrophage markers was increased in ovarian cancer cells. PD-L1, vascular endothelial growth factor (VEGF), Interleukin (IL)-6, IL-10, IL-12, signal transducer and activator of transcription 3 (STAT3), B-cell lymphoma 2 (BCL2), multidrug resistance 1 (MDR1), and colony stimulating factor 1 (CSF-1) were upregulated. Notably, PD-L1 was upregulated in both the ovarian cancer cells and macrophages. Ovarian cancer cells co-cultured with macrophages exhibited statistically significant carboplatin resistance compared to single-cultured ovarian cancer cells. PD-L1 silencing induced chemosensitivity in both types of co-cultured ovarian cancer cells. However, IHC results revealed no correlation between PD-L1 expression and patient survival or cancer stage. CD68 expression was significantly increased in cancer cells compared to normal or benign ovarian tumor cells, but it was not associated with the survival outcomes of ovarian cancer patients. Our study demonstrated that ovarian cancer cells interact with macrophages to induce the M2 phenotype. We also established that PD-L1 upregulation in both ovarian cancer cells and macrophages is a key factor for carboplatin chemoresistance.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910707/?tool=EBI
spellingShingle Yong Soo Jang
Tae Wan Kim
Jae Sung Ryu
Hye Jeong Kong
Si Hyeong Jang
Gye Hyun Nam
Jae Hoon Kim
Seob Jeon
Upregulation of programmed death ligand-1 in tumor-associated macrophages affects chemotherapeutic response in ovarian cancer cells
PLoS ONE
title Upregulation of programmed death ligand-1 in tumor-associated macrophages affects chemotherapeutic response in ovarian cancer cells
title_full Upregulation of programmed death ligand-1 in tumor-associated macrophages affects chemotherapeutic response in ovarian cancer cells
title_fullStr Upregulation of programmed death ligand-1 in tumor-associated macrophages affects chemotherapeutic response in ovarian cancer cells
title_full_unstemmed Upregulation of programmed death ligand-1 in tumor-associated macrophages affects chemotherapeutic response in ovarian cancer cells
title_short Upregulation of programmed death ligand-1 in tumor-associated macrophages affects chemotherapeutic response in ovarian cancer cells
title_sort upregulation of programmed death ligand 1 in tumor associated macrophages affects chemotherapeutic response in ovarian cancer cells
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910707/?tool=EBI
work_keys_str_mv AT yongsoojang upregulationofprogrammeddeathligand1intumorassociatedmacrophagesaffectschemotherapeuticresponseinovariancancercells
AT taewankim upregulationofprogrammeddeathligand1intumorassociatedmacrophagesaffectschemotherapeuticresponseinovariancancercells
AT jaesungryu upregulationofprogrammeddeathligand1intumorassociatedmacrophagesaffectschemotherapeuticresponseinovariancancercells
AT hyejeongkong upregulationofprogrammeddeathligand1intumorassociatedmacrophagesaffectschemotherapeuticresponseinovariancancercells
AT sihyeongjang upregulationofprogrammeddeathligand1intumorassociatedmacrophagesaffectschemotherapeuticresponseinovariancancercells
AT gyehyunnam upregulationofprogrammeddeathligand1intumorassociatedmacrophagesaffectschemotherapeuticresponseinovariancancercells
AT jaehoonkim upregulationofprogrammeddeathligand1intumorassociatedmacrophagesaffectschemotherapeuticresponseinovariancancercells
AT seobjeon upregulationofprogrammeddeathligand1intumorassociatedmacrophagesaffectschemotherapeuticresponseinovariancancercells